M de Forni|J P Armand - JoVE Visualize

Showing results (1-10 of 170) with videos related to

Pageof 17

Sort By:

Current Opinion in Oncology|July 1, 1994

Cardiotoxicity of chemotherapyM de Forni, J P Armand

Fundamental & Clinical Pharmacology|January 1, 1990

Specificity of the phase I trial for cytotoxic drugs in oncologyJ P Armand, M Klink-Alakl, G Recondo, et al.

Cancer Chemotherapy and Pharmacology|January 1, 1995

Phase I and pharmacology study of flavone acetic acid administered two or three times weekly without alkalinizationM de Forni, G G Chabot, J P Armand, et al.

Infection|May 1, 1991

Flucytosine conversion to fluorouracil in humans: does a correlation with gut flora status exist? A report of two cases using fluorine-19 magnetic resonance spectroscopyM C Malet-Martino, R Martino, M de Forni, et al.

European Journal of Cancer (Oxford, England : 1990)|July 1, 1995

CPT-11 (irinotecan) in the treatment of colorectal cancerJ P Armand, M Ducreux, M Mahjoubi, et al.

European Journal of Cancer (Oxford, England : 1990)|January 1, 1993

Phase I and pharmacokinetic study of brequinar (DUP 785; NSC 368390) in cancer patientsM de Forni, G G Chabot, J P Armand, et al.

European Journal of Cancer (Oxford, England : 1990)|January 1, 1993

Phase II study of pirarubicin (THP) in patients with cervical, endometrial and ovarian cancer: study of the Clinical Screening Group of the European Organization for Research and Treatment of Cancer (EORTC)J Chauvergne, P Fumoleau, P Cappelaere, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1995

Population pharmacokinetics and pharmacodynamics of irinotecan (CPT-11) and active metabolite SN-38 during phase I trialsG G Chabot, D Abigerges, G Catimel, et al.

British Journal of Cancer|October 3, 1999

A phase II study of docetaxel in patients with metastatic squamous cell carcinoma of the head and neckC Couteau, N Chouaki, S Leyvraz, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996

Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I studyG G Chabot, J P Armand, C Terret, et al.

Pageof 17

Showing results (1-10 of 170) with videos related to

Sort By:

Pageof 17

Current Opinion in Oncology|July 1, 1994

Cardiotoxicity of chemotherapyM de Forni, J P Armand

Fundamental & Clinical Pharmacology|January 1, 1990

Specificity of the phase I trial for cytotoxic drugs in oncologyJ P Armand, M Klink-Alakl, G Recondo, et al.

Cancer Chemotherapy and Pharmacology|January 1, 1995

Phase I and pharmacology study of flavone acetic acid administered two or three times weekly without alkalinizationM de Forni, G G Chabot, J P Armand, et al.

Infection|May 1, 1991

Flucytosine conversion to fluorouracil in humans: does a correlation with gut flora status exist? A report of two cases using fluorine-19 magnetic resonance spectroscopyM C Malet-Martino, R Martino, M de Forni, et al.

European Journal of Cancer (Oxford, England : 1990)|July 1, 1995

CPT-11 (irinotecan) in the treatment of colorectal cancerJ P Armand, M Ducreux, M Mahjoubi, et al.

European Journal of Cancer (Oxford, England : 1990)|January 1, 1993

Phase I and pharmacokinetic study of brequinar (DUP 785; NSC 368390) in cancer patientsM de Forni, G G Chabot, J P Armand, et al.

European Journal of Cancer (Oxford, England : 1990)|January 1, 1993

Phase II study of pirarubicin (THP) in patients with cervical, endometrial and ovarian cancer: study of the Clinical Screening Group of the European Organization for Research and Treatment of Cancer (EORTC)J Chauvergne, P Fumoleau, P Cappelaere, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1995

Population pharmacokinetics and pharmacodynamics of irinotecan (CPT-11) and active metabolite SN-38 during phase I trialsG G Chabot, D Abigerges, G Catimel, et al.

British Journal of Cancer|October 3, 1999

A phase II study of docetaxel in patients with metastatic squamous cell carcinoma of the head and neckC Couteau, N Chouaki, S Leyvraz, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996

Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I studyG G Chabot, J P Armand, C Terret, et al.

Pageof 17